YHB Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$354K Hold
568
0.02% 251
2026
Q1
$439K Hold
568
0.03% 222
2025
Q4
$438K Sell
568
-5
-0.9% -$3.4K 0.03% 222
2025
Q3
$322K Sell
573
-2
-0.3% -$1.13K 0.02% 251
2025
Q2
$302K Hold
575
0.02% 254
2025
Q1
$365K Sell
575
-2
-0.3% -$1.38K 0.03% 225
2024
Q4
$411K Hold
577
0.03% 210
2024
Q3
$607K Hold
577
0.05% 189
2024
Q2
$606K Hold
577
0.05% 183
2024
Q1
$555K Sell
577
-56
-9% -$53.2K 0.05% 186
2023
Q4
$556K Sell
633
-12
-2% -$9.88K 0.05% 181
2023
Q3
$531K Sell
645
-25
-4% -$19.6K 0.05% 185
2023
Q2
$481K Sell
670
-37
-5% -$28.5K 0.04% 193
2023
Q1
$581K Sell
707
-72
-9% -$54.3K 0.06% 178
2022
Q4
$562K Sell
779
-14
-2% -$10.3K 0.06% 173
2022
Q3
$546K Hold
793
0.06% 182
2022
Q2
$469K Sell
793
-10
-1% -$6.5K 0.05% 190
2022
Q1
$561K Hold
803
0.05% 190
2021
Q4
$507K Hold
803
0.04% 210
2021
Q3
$486K Hold
803
0.04% 202
2021
Q2
$449K Hold
803
0.04% 206
2021
Q1
$404K Sell
803
-10
-1% -$4.87K 0.04% 213
2020
Q4
$393K Buy
813
+3
+0.4% +$1.62K 0.04% 208
2020
Q3
$453K Sell
810
-100
-11% -$60.6K 0.05% 195
2020
Q2
$568K Hold
910
0.08% 127
2020
Q1
$444K Buy
910
+10
+1% +$4.13K 0.08% 125
2019
Q4
$338K Sell
900
-800
-47% -$269K 0.05% 147
2019
Q3
$472K Buy
+1,700
New +$503K 0.07% 134

Other funds holding REGN

YHB Investment Advisors's REGN Position: Q2 2026 in Review

YHB Investment Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 568 shares worth $354K. The position accounts for 0.02% of the portfolio, ranked #251.

YHB Investment Advisors first reported a position in REGN in Q3 2019 and has held it in 28 quarters since. The position peaked at $607K in Q3 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • YHB Investment Advisors held 568 shares of Regeneron Pharmaceuticals worth $354K as of Q2 2026.
  • YHB Investment Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.02% of YHB Investment Advisors's portfolio in Q2 2026, its #251 holding.
  • YHB Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
  • YHB Investment Advisors's Regeneron Pharmaceuticals position peaked at $607K in Q3 2024.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.